Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Knop

Showing results (101-110 of 509) with videos related to

Pageof 51
Sort By:
International Journal of Sports Medicine|November 19, 2011
Sport and oxidative stress in oncological patientsK Knop, R Schwan, M Bongartz, et al.
BMJ Open|September 17, 2013
Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: protocol for systematic review and meta-analysis of clinical studiesUlrich Rohde, Nora Hedbäck, Lise L Gluud, et al.
Diabetes, Obesity & Metabolism|January 21, 2017
Glucagon-like peptide-1 receptor agonists and risk of acute pancreatitis in patients with type 2 diabetesHeidi Storgaard, Frederik Cold, Lise L Gluud, et al.
Clinical Epidemiology|January 22, 2024
The Epidemiology of Bile Acid Diarrhea in Denmark [Response to Letter]Martin L Kårhus, Anne-Marie Ellegaard, Filip K Knop, et al.
Gastro Hep Advances|May 7, 2026
Letter to the Editor Regarding "<i>Ruminococcus gnavus</i> and Biofilm Markers in Feces From Primary Bile Acid Diarrhea Patients Indicate New Disease Mechanisms and Potential for Diagnostic Testing"Martin L Kårhus, Dennis S Nielsen, Filip K Knop, et al.
Diabetes Care|April 29, 2011
Loss of incretin effect is a specific, important, and early characteristic of type 2 diabetesJens J Holst, Filip K Knop, Tina Vilsbøll, et al.
Diabetologia|January 17, 2007
Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitusF K Knop, T Vilsbøll, S Madsbad, et al.
Current Diabetes Reports|October 27, 2014
Glucagon and type 2 diabetes: the return of the alpha cellAsger Lund, Jonatan I Bagger, Mikkel Christensen, et al.
Diabetes|January 22, 2017
Glucagon and Amino Acids Are Linked in a Mutual Feedback Cycle: The Liver-α-Cell AxisJens J Holst, Nicolai J Wewer Albrechtsen, Jens Pedersen, et al.
Diabetes, Obesity & Metabolism|November 6, 2015
Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: a systematic review and meta-analysisU Rohde, N Hedbäck, L L Gluud, et al.
Pageof 51

Showing results (101-110 of 509) with videos related to

Sort By:
Pageof 51
International Journal of Sports Medicine|November 19, 2011
Sport and oxidative stress in oncological patientsK Knop, R Schwan, M Bongartz, et al.
BMJ Open|September 17, 2013
Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: protocol for systematic review and meta-analysis of clinical studiesUlrich Rohde, Nora Hedbäck, Lise L Gluud, et al.
Diabetes, Obesity & Metabolism|January 21, 2017
Glucagon-like peptide-1 receptor agonists and risk of acute pancreatitis in patients with type 2 diabetesHeidi Storgaard, Frederik Cold, Lise L Gluud, et al.
Clinical Epidemiology|January 22, 2024
The Epidemiology of Bile Acid Diarrhea in Denmark [Response to Letter]Martin L Kårhus, Anne-Marie Ellegaard, Filip K Knop, et al.
Gastro Hep Advances|May 7, 2026
Letter to the Editor Regarding "<i>Ruminococcus gnavus</i> and Biofilm Markers in Feces From Primary Bile Acid Diarrhea Patients Indicate New Disease Mechanisms and Potential for Diagnostic Testing"Martin L Kårhus, Dennis S Nielsen, Filip K Knop, et al.
Diabetes Care|April 29, 2011
Loss of incretin effect is a specific, important, and early characteristic of type 2 diabetesJens J Holst, Filip K Knop, Tina Vilsbøll, et al.
Diabetologia|January 17, 2007
Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitusF K Knop, T Vilsbøll, S Madsbad, et al.
Current Diabetes Reports|October 27, 2014
Glucagon and type 2 diabetes: the return of the alpha cellAsger Lund, Jonatan I Bagger, Mikkel Christensen, et al.
Diabetes|January 22, 2017
Glucagon and Amino Acids Are Linked in a Mutual Feedback Cycle: The Liver-α-Cell AxisJens J Holst, Nicolai J Wewer Albrechtsen, Jens Pedersen, et al.
Diabetes, Obesity & Metabolism|November 6, 2015
Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: a systematic review and meta-analysisU Rohde, N Hedbäck, L L Gluud, et al.
Pageof 51